日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH/EAHP Workshop

慢性淋巴细胞白血病/小淋巴细胞淋巴瘤和 B 细胞幼淋巴细胞白血病的进展和转化:2021 年 SH/EAHP 研讨会报告

Magdalena Czader, Catalina Amador, James R Cook, Devang Thakkar, Clay Parker, Sandeep S Dave, Ahmet Dogan, Amy S Duffield, Reza Nejati, German Ott, Wenbin Xiao, Mariusz Wasik, John R Goodlad0

FLT3-ITD cooperates with Rac1 to modulate the sensitivity of leukemic cells to chemotherapeutic agents via regulation of DNA repair pathways

FLT3-ITD 与 Rac1 协同作用,通过调节 DNA 修复通路来调节白血病细胞对化疗药物的敏感性

Min Wu, Li Li, Max Hamaker, Donald Small, Amy S Duffield

Knock-in of the Wt1 R394W mutation causes MDS and cooperates with Flt3/ITD to drive aggressive myeloid neoplasms in mice

Wt1 R394W 突变敲入可导致 MDS,并与 Flt3/ITD 协同作用,引发小鼠侵袭性髓系肿瘤

Colleen E Annesley, Cara Rabik, Amy S Duffield, Rachel E Rau, Daniel Magoon, Li Li, Vicki Huff, Donald Small, David M Loeb, Patrick Brown

Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapy

Epstein-Barr病毒阴性霍奇金淋巴瘤中Th17免疫微环境:对免疫治疗的启示

Amy S Duffield ,Maria Libera Ascierto ,Robert A Anders ,Janis M Taube ,Alan K Meeker ,Shuming Chen ,Tracee L McMiller ,Neil A Phillips ,Haiying Xu ,Aleksandra Ogurtsova ,Alan E Berger ,Drew M Pardoll ,Suzanne L Topalian ,Richard F Ambinder

Tumor-Infiltrating Macrophages in Post-Transplant, Relapsed Classical Hodgkin Lymphoma Are Donor-Derived

移植后复发的经典霍奇金淋巴瘤中的肿瘤浸润巨噬细胞来自供体

Genevieve M Crane, Mark A Samols, Laura A Morsberger, Raluca Yonescu, Michele L Thiess, Denise A S Batista, Yi Ning, Kathleen H Burns, Milena Vuica-Ross, Michael J Borowitz, Christopher D Gocke, Richard F Ambinder, Amy S Duffield

Dnmt3a deletion cooperates with the Flt3/ITD mutation to drive leukemogenesis in a murine model

Dnmt3a 缺失与 Flt3/ITD 突变协同作用,在小鼠模型中驱动白血病发生

Jennifer L Poitras, Diane Heiser, Li Li, Bao Nguyen, Kozo Nagai, Amy S Duffield, Christopher Gamper, Donald Small

FLT3 kinase inhibitor TTT-3002 overcomes both activating and drug resistance mutations in FLT3 in acute myeloid leukemia

FLT3 激酶抑制剂 TTT-3002 可克服急性髓系白血病中 FLT3 的激活突变和耐药性突变

Hayley S Ma, Bao Nguyen, Amy S Duffield, Li Li, Allison Galanis, Allen B Williams, Patrick A Brown, Mark J Levis, Daniel J Leahy, Donald Small

FLT3/D835Y mutation knock-in mice display less aggressive disease compared with FLT3/internal tandem duplication (ITD) mice

FLT3/D835Y 突变敲入小鼠与 FLT3/内部串联重复 (ITD) 小鼠相比,疾病侵袭性较低

Emily Bailey, Li Li, Amy S Duffield, Hayley S Ma, David L Huso, Don Small